Area of research
Oncology · Economics and Econometrics
Research interest
Research interests include Cancer survivorship and care, Cancer Treatment and Pharmacology, Economic and Financial Impacts of Cancer, and Breast Cancer Treatment Studies.
NCCN Guidelines® Insights: Survivorship, Version 2.2025
NCCN Guidelines® Insights: Survivorship, Version 2.2024
NCCN Guidelines® Insights: Survivorship, Version 1.2023
Getting ready for real‐world use of electronic patient‐reported outcomes (ePROs) for patients with cancer: A National Comprehensive Cancer Network ePRO Workgroup paper
NCCN Guidelines® Insights: Survivorship, Version 1.2022
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131
Survivorship, Version 1.2021
Addressing the needs of cancer survivors during the COVID-19 pandemic
NCCN Guidelines Insights: Survivorship, Version 2.2020
NCCN Guidelines Insights: Survivorship, Version 2.2019
Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor–Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group
Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103.
Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis